BPA Call 36C25926A0033-36C25926N0463
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $40K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78753, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 19 awarded a purchase order to Natera Inc. for genetic testing with a ceiling value of $82,500, effective June 6, 2025, with ultimate completion by June 5, 2026. Performance occurs in Austin, Texas. The order procures specialized genetic and molecular diagnostic testing services, including cell-free DNA analysis and advanced genomic testing for oncology and precision medicine applications, delivered through Natera's CLIA-certified and CAP-accredited...
- Natera Inc. has been awarded a delivery order valued at $73.5K by the Veterans Integrated Service Network 10 (VISN 10), a civilian component of the Department of Veterans Affairs, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services to support VA research initiatives. The contract, awarded on March 3, 2026, with an ultimate completion date of March 2, 2027, operates under a firm fixed-price structure with no set-aside designation, reflecting...
- Veterans Integrated Service Network 17 awarded a purchase order to Natera Inc. for $328,300 on September 27, 2024, covering tumor whole exome sequencing and peripheral blood circulating tumor DNA testing services with an ultimate completion date of September 26, 2029. No set-aside was used. Work is performed in Austin, Texas. The order supports a research study of esophageal cancer patients, requiring the contractor to develop assays from tissue samples combining tumor whole exome sequencing...
- The U.S. Department of Veterans Affairs (VA) Headquarters awarded a new delivery order worth $499,447.00 to Natera Inc., a global leader in cell-free DNA testing. This order extends the period of performance for six months under an existing indefinite delivery contract between the VA and Natera valued at up to $6.72 million over two years. The contract is for Natera to provide minimal residual disease testing services, which analyze cell-free DNA biomarkers in patient blood samples to detect...
- Veterans Integrated Service Network 10 awarded a $157,000 definitive contract to Natera Inc. for Natera Kidney Disease Genetic Panel Testing on April 7, 2026, under firm fixed-price terms with no set-aside. Place of performance is Indianapolis, IN. The originating sources-sought notice, posted March 10, 2026, describes laboratory testing services specializing in kidney disease genetic analysis across three specialized service lines: Kidney Gene Panel Testing (analyzing over 380 genes), Kidney...
- The U.S. Department of Veterans Affairs (VA) has awarded a $35,000 firm fixed-price delivery order contract to Natera Inc., a leading biotechnology company, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of cancer research. This contract is not designated as a set-aside. Natera has been a prime contractor for the VA, providing advanced genomic testing and analysis services, including tumor whole exome sequencing, minimal residual...
- Veterans Integrated Service Network 19 issued a BPA call to Exact Sciences Corporation for Genomic Health genetic testing under the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule, with a ceiling value of $73,167.28 and an award date of October 1, 2024. Place of performance is Aurora, Colorado. The ultimate completion date is September 30, 2025. The call is firm fixed price. This is Option Year 4 of an existing BPA framework for specialized genomic and molecular...
- Veterans Integrated Service Network 16 awarded a purchase order to Natera Inc. valued at $550,000 on July 13, 2026, for genetic testing services. Place of performance is North Little Rock, Arkansas. The order covers three specialized genetic tests—Renasight, Prospera, and Signatera—performed at a CLIA-certified and CAP-accredited reference laboratory. Required turnaround time is five business days from specimen receipt with a specimen rejection rate not to exceed 2 percent. The contractor must...
- This $92,391 firm-fixed-price delivery order was awarded by the U.S. Department of Veterans Affairs (VA) to Natera Inc., a leading biotechnology company specializing in advanced genomic and molecular diagnostic testing services. The contract is for minimal residual disease testing services, which support the VA's research and patient care initiatives in oncology and precision medicine. Natera has been awarded multiple federal contracts with the VA, including indefinite delivery contracts...
- The Department of Veterans Affairs (VA) headquarters awarded an indefinite delivery contract to Natera Inc., doing business as Natera, for up to $6.72 million over two years. This contract covers the delivery of minimal residual disease testing services to detect remaining cancer cells in patients after initial treatment, guiding further treatment decisions. An initial delivery order worth $496,460 was issued to fund research and development activities related to this testing through Fiscal Year...